ACT’s “Therapeutic Cloning” — Help or Hype?
January 2002 (Volume 2 Issue 1)
[1] Our heated summer-time debates over human embryonic stem cell research were all but forgotten until we were jolted over the sleepy Thanksgiving weekend by an announcement from researchers at Advanced Cell Technology (ACT), a small biotech company in Massachusetts. On TV screens, in the pages of “U.S. News & World Report,” and online in […]